Bio-Techne Corp.
Charles R. Kummeth, CEO
Exercised options: 38,118 Price: $67.46
Shares sold: 38,118 Price: $217.28-$221.13
Date: Jan. 2-6 Directly holds: 130,189
Calyxt Inc.
Philippe Dumont, director
Shares sold: 236 Price: $7.60
Date: Jan. 3 Directly holds: 1,762
Anna Kozicz-Stankiewicz, director
Shares sold: 245 Price: $7.65
Date: Jan. 3 Directly holds: 3,655
Donaldson Co. Inc.
Amy C. Becker, officer
Exercised options: 6,000 Price: $21.14
Date: Jan. 2 Directly holds: na
Surmodics Inc.
Gary R. Maharaj, CEO
Shares sold: 702 Price: $41.08
Date: Jan. 2 Directly holds: 142,885
Tactile Systems Technology Inc.
Gerald R. Mattys, CEO
Exercised options: 25,000 Price: $0.96
Date: Dec. 31 Directly holds: na
Tennant Co.
Hans Chris Killingstad, CEO
Exercised options: 12,843 Price: $24.21
Shares sold: 12,843 Price: $77.65–$77.89
Date: Jan. 2 Directly holds: 158,911
Winmark Corp.
Ronald G. Olson, beneficial owner
Shares sold: 5,000 Price: $198.32
Date: Jan. 6 Directly holds: 398,311
Late night TV shows announce their return after Hollywood writers end strike
Stock market today: Wall Street holds steadier as its September swoon eases a bit
Britain approves new North Sea oil drilling in welcome news for the industry but not activists
